210 reports of this reaction
5.1% of all NORETHINDRONE ACETATE reports
#1 most reported adverse reaction
HOT FLUSH is the #1 most commonly reported adverse reaction for NORETHINDRONE ACETATE. There are 210 FDA adverse event reports linking NORETHINDRONE ACETATE to HOT FLUSH. This represents approximately 5.1% of all 4,107 adverse event reports for this drug.
Patients taking NORETHINDRONE ACETATE who experience hot flush should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HOT FLUSH is moderately reported among NORETHINDRONE ACETATE users, representing a notable but not dominant share of adverse events.
In addition to hot flush, the following adverse reactions have been reported for NORETHINDRONE ACETATE:
The following drugs have also been linked to hot flush in FDA adverse event reports:
HOT FLUSH has been reported as an adverse event in 210 FDA reports for NORETHINDRONE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HOT FLUSH accounts for approximately 5.1% of all adverse event reports for NORETHINDRONE ACETATE, making it one of the most commonly reported side effect.
If you experience hot flush while taking NORETHINDRONE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.